Skin Cancer

SKIN CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Tumor-Infiltrating Lymphocytes Outperform Ipilimumab in Advanced Melanoma

Tumor-infiltrating lymphocytes can improve progression-free survival, when compared with ipilimumab, in patients with advanced melanoma, a phase 3 trial suggests.
First-Line Immune Checkpoint Inhibitors Underused in Metastatic Melanoma

First-line immune checkpoint inhibitors have improved survival in patients with metastatic melanoma but remain underused in this population.
Low-Dose Methotrexate May Increase Risk of Melanoma

Exposure to low-dose methotrexate is associated with an increased risk of melanoma, according to a meta-analysis of 17 studies.
No Survival Benefit With T-VEC in Advanced Melanoma

Adding T-VEC to pembrolizumab does not improve survival in patients with advanced melanoma, a phase 3 study suggests.
Disparities in Use of Immunotherapies Persist After FDA Approval

Some disparities that existed before FDA approval persisted after approval, and some new disparities emerged after FDA approval.

SKIN CANCER NEWS

A pregnant woman

Adverse Birth Outcomes More Common Among AYAs With Cancer During Pregnancy

March 22, 2023

IV infusion

Comparable Outcomes With and Without Neoadjuvant Therapy in High-Risk Melanoma

March 22, 2023

Nicotinamide Does Not Prevent Keratinocyte Cancers in Organ Recipients

March 22, 2023

Personalized ctDNA Monitoring Can Predict Outcomes in Advanced Melanoma

March 15, 2023

Hands holding blister pack of pills

Certain Antibiotics May Reduce the Efficacy of Certain ICIs in Cancer Patients

March 10, 2023

Next post in Skin Cancer

Nicotinamide Does Not Prevent Keratinocyte Cancers in Organ Recipients